SEARCH

SEARCH BY CITATION

References

  • 1
    WHO Report 1996. Geneva, Switzerland, 1996.
  • 2
    Maynard JE. Hepatitis B. Global importance of and need for control. Vaccine 1990; 8(Suppl):S18S20.MEDLINE
  • 3
    Lai CL. Chronic hepatitis B in Hong Kong: immunisation strategies for the control of hepatitis B virus infection. In: ZuckermanAJ, ed. Hepatitis B in the Asian-Pacific Region. Screening, Diagnosis and Control. Vol. 1. London: Royal College of Physicians of London, 1997:7987.
  • 4
    Maynard JE, Kare MA, Alter MJ, Hadler SC. Control of hepatitis B by immunization: global perspective. In: ZukermanAJ, ed. Viral Hepatitis and Liver Disease. New York: Alan R. Liss. 1988:967969.
  • 5
    Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the “healthy” HBsAg carrier state. Hepatology 1987; 4:758763.
  • 6
    Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrainatoavina I, Benhamou JP, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 1997; 27:251258.MEDLINE
  • 7
    Marcellin P, Martinot-Peignoux M, Loriot MA, Giostra E, Boyer N, Thiers V, Benhamou JP. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med 1990; 112:227228.MEDLINE
  • 8
    Kaneko S, Miller R, Di Bisceglie AM, Feinstone SM, Hoofnagle JH, Purcell RH. Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Gastroenterology 1990; 99:799804.MEDLINE
  • 9
    Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, Erlinger S, et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 1992; 15:3236.MEDLINE
  • 10
    Kuhns M, McNamara A, Mason A, Campbell A, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992; 103:16491656.MEDLINE
  • 11
    Brook MG, Chan G, Yap I, Karayiannis P, Lever AML, Jacyna M, Main J, et al. Randomized controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. Br Med J 1989; 299:652659.
  • 12
    Alexander GJM, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston ALWF, Williams R. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987; 2:6669.MEDLINE
  • 13
    Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, DiBisceglie AM, Hallahan C, et al. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95:13181325.MEDLINE
  • 14
    Saracco G, Mazzella G, Rosina F, Cancellierei C, Lattore V, Raise E, Rocca G, et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989; 10:336341.MEDLINE
  • 15
    Perrillo RP. Treatment of chronic hepatitis B with interferon: experience in western countries. Semin Liver Dis 1989; 9:240248.MEDLINE
  • 16
    Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen–positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119:312323.MEDLINE
  • 17
    Lok ASF, Lai CL, Wu PC, Lau JYN, Leung EKY, Wong LSK. Treatment of chronic hepatitis B with interferon: experience in Asian patients. Semin Liver Dis 1989; 9:249253.MEDLINE
  • 18
    Derso A, Boxall EH, Tarlow MJ, Flewett TH. Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J 1978; 1:949952.MEDLINE
  • 19
    Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, Ma OCK, et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102:20912097.MEDLINE
  • 20
    Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Haussinger D. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334:14221427.MEDLINE
  • 21
    Wong JB, Koff RS, Tine F, Pauker SG. Cost-effectiveness of interferon-2b treatment for hepatitis B antigen–positive chronic hepatitis B. Ann Intern Med 1995; 122:664675.MEDLINE
  • 22
    Lau DT, Everhart J, Kleiner DE, Park Y, Vergalla J, Schmid P, Hoofnagle JH. Long-term follow up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997; 113:16601667.MEDLINE
  • 23
    Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991; 114:629634.MEDLINE
  • 24
    Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen–positive chronic hepatitis B: implications for interferon therapy. J Infect Dis 1997; 176:845850.MEDLINE
  • 25
    Chen DS. Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 1993; 8:470475.MEDLINE
  • 26
    Lai CL, Gregory PB, Wu PC, Lok ASF, Wong KP, Ng MMT. Hepatocellular carcinoma in Chinese males and females. Cancer 1987; 60:11071110.MEDLINE
  • 27
    Lai CL, Lam KC, Wong KP, Wu PC, Todd D. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981; 47:27462755.MEDLINE
  • 28
    Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: OkudaK, IshakKG, eds., Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987:7180.
  • 29
    Chang MH, Chen DS, Hsu HC, Hsu HY, Lee CY. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989; 64:23772380.MEDLINE
  • 30
    Sung JL, Chen DS. Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan. Scand J Gastroenterol 1980; 15:321324.MEDLINE
  • 31
    Yuen MF, Wong WM, Cheng CC, Wu CH, Wu PC, Lai CL. Natural history of chronic hepatitis B in the Chinese: prognostic significance of HBeAg/anti-HBe positivity [Abstract]. Hepatology 1997; 26(Suppl):316A.
  • 32
    Liaw YF. Monitoring disease progression and the effect of treatment in chronic hepatitis B. In: ZuckermanAJ, ed. Hepatitis B in the Asian-Pacific Region. Screening, Diagnosis and Control. London: Royal College of Physicians of London, 1997:123137.
  • 33
    Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999; 29:971975.MEDLINE
  • 34
    Carithers RL. Effect of interferon on hepatitis B. Lancet 1998; 351:157.MEDLINE
  • 35
    Evans AA, Fine MK, London WT. Do Asian HBV carriers differ from non-Asian carriers? Lancet 1998; 351:12851286.MEDLINE
  • 36
    Lai CL, Lok ASF, Lin HJ, Wu PC, Yeoh EK, Yeung CY. Placebo-controlled trial of recombinant 2-interferon in Chinese HBsAg-carrier children. Lancet 1987; 2:877880.MEDLINE
  • 37
    Lai CL, Lin HJ, Lau JYN, Lok AS, Wu PC, Chung HT, Wong LK, et al. Effect of recombinant alpha-2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 1991; 78:155163.MEDLINE
  • 38
    Lok ASF, Lai CL, Wu PC, Leung EKY. Long-term follow up in a randomized controlled trial of recombinant alpha-2 interferon in Chinese patients with chronic hepatitis B infection. Lancet 1988; 2:298302.MEDLINE
  • 39
    Chung HT, Lok AS, Lai CL. Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction. J Hepatol 1993; 17:208214.MEDLINE
  • 40
    Davis GL. Chronic hepatitis. In: KaplowitzN, ed. Liver and Biliary Disease. 2nd ed. Baltimore: Williams & Wilkins, 1996:330337.
  • 41
    Perrillo RP. Treatment of chronic hepatitis B with interferon: experience in western countries. Semin Liver Dis 1989; 9:240248.MEDLINE
  • 42
    Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987; 92:18391843.MEDLINE
  • 43
    International Interferon-α Hepatocellular Carcinoma Study Group. Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 1998; 351:15351539.MEDLINE
  • 44
    Lau JY, Lai CL, Lin HJ, Lok AS, Liang RH, Wu PC, Chan TK, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy of lymphoma patients. Q J Med 1989; 73:911917.MEDLINE
  • 45
    Kumada K, Mizokami M, Orito E, Kamejima N, Yamamoto M, Oba K, Tokuda Y, et al. A case of HBsAg positive liver cirrhosis who died after withdrawal of steroid. Kansenshogaku Zasshi 1992; 66(1):99103.MEDLINE
  • 46
    Koga Y, Kumashiro R, Yasumoto K, Shakado S, Ono N, Noguchi H, Nagata K, et al. Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. Intern Med 1992; 31:208213.MEDLINE
  • 47
    Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339:6168.MEDLINE